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Abstract: 
Diabetics are at increased risk for coronary heart disease even after accounting for other risk factors, and the 
impact of diabetes mellitus may be particularly strong among females and at adverse levels of other risk factors. 
Therefore, the independent relation of diabetes to arteriographically-documented coronary artery disease (CAD) 
was examined in 5620 patients (18% female) referred to two Milwaukee hospitals from 1972 to 1986. As 
assessed by questionnaire, the prevalence of diabetes mellitus among these patients was 8% (n = 466). 
Diabetics had increased CAD (assessed by the number and severity of stenoses) even after accounting for levels 
of total and high-density lipoprotein cholesterol, triglycerides, hypertension, obesity, smoking, and alcohol 
consumption. In addition, regression analyses indicated that as compared with nondiabetics, female diabetics 
tended to have a greater increase in CAD than did male diabetics (p = 0.06 for sex x diabetes interaction), 
Although adverse levels of other risk factors did not increase the association between diabetes and CAD, female 
diabetics who were using oral hypoglycemics or insulin showed almost a two-fold increase in CAD severity    
(p <0.01). Results suggest that the higher relative risk of coronary heart disease among female (vs male) 
diabetics may be due to a proportionately greater increase in atherosclerosis. 




Autopsy [1, 2], clinical [3, 4], and prospective epidemiologic studies [5-11] indicate that diabetes mellitus 
confers at least a twofold increased risk for coronary heart disease (CHD) mortality. Although the principal 
cause of this arterial disease among both insulin-dependent (type 1) and noninsulin-dependent (type 2) diabetes 
is atherosclerosis, the risk of congestive heart failure is also increased [12]. Furthermore, with few exceptions 
[10], diabetes is more strongly related to CHD among premenopausal females than in similarly aged males. 
 
Ecologic and migrant studies suggest that the increased CHD mortality among diabetics in industrialized 
countries may be due to an increased prevalence of hyperlipidemia, obesity, and hypertension [13]. Although 
diabetics show an increased clustering of risk factors [14], this aggregation accounts for only a small proportion 
of their excess CHD, and diabetes has remained an independent predictor of clinical disease in all prospective 
studies [5-11]. In addition, diabetics who are young [15], who smoke cigarettes [16], are hypertensive [15], 
obese [17], hyperlipidemic [18], or who have decreased levels of high-density lipoprotein (HDL) cholesterol [6] 
may be at very high risk for CHD. 
 
Many of the clinical and prospective studies of diabetics have been limited by small numbers of deaths, and all 
have relied on clinical diagnoses of CHD, without knowledge of the underlying anatomic substrate. Although 
differences in coronary atherosclerosis between diabetics and nondiabetics have been examined in arteriography 
studies [18-24], possible effects of other risk factors have not always been considered. However, Abadie et al. 
[24] found that diabetics did not have increased CAD as compared with controls matched for age, sex, blood 
pressure, total cholesterol, and triglycerides. Another report [18] suggested that the increased CAD among 
diabetics was particularly evident at elevated triglyceride levels, In contrast, in a previous analysis of 2006 
patients [21], we found that diabetics had more severe CAD independently of lipid levels, smoking, 
hypertension, obesity, and alcohol intake; HDL cholesterol levels, however, were not included in these 
analyses. 
 
The objective of the current study of over 5000 patients is to examine sex differences in the relation of diabetes 
to CAD, and possible interactions of diabetes with age, obesity, hypertension, cigarette smoking, and levels of 
plasma lipids and HDL cholesterol. In addition, the relative importance of other risk factors in diabetics and 
nondiabetics is compared. Possible referral biases inherent in hospital-based studies of diabetics are discussed. 
 
METHODS 
Population and disease status 
The Milwaukee Cardiovascular Data Registry is a clinical database consisting of patients referred to selected 
Milwaukee hospitals (St Luke's and Zablocki Veterans Administration Medical Center) for diagnostic coronary 
angiography. The current study is restricted to whites who were examined from 1972 to 1986, and for whom 
plasma levels of both total cholesterol and triglycerides were measured. (Only 27 black diabetics underwent 
arteriography during this period.) The mean age of the 5620 patients (18% female) was 55 years (range = 24-84 
years), with approximately two-thirds between 50 and 69 years of age. A prior myocardial infarction was 
reported by 45%, and 74% reported chest pain. Of the patients with chest pain, its onset was reported within 1 
year of the arteriography for 37%, 1-2 years before arteriography for 35%, and >2 years before arteriography 
for 29%. 
 
Arteriograms were evaluated by a radiologist and cardiologist, without knowledge of risk-factor data. 
Reductions in lumen diameter (0%, 1-50%, 51-74%, 75-89%, 90-99% and 100%) in the left main, left anterior 
descending circumflex, and right coronary arteries were incorporated (summed) into an occlusion score 
indicating the overall severity of CAD. As previously reported [21, 25] a scale suggested by Rowe et al. [26] 
was modified, with a score of 0 representing no observed CAD, and a score of 300 denoting total occlusion of 
the major arteries. The number of diseased vessels (excluding the left main) was also calculated according to the 
number of ≥75% stenoses; this scale ranged from 0 to 3. (The correlation between the overall occlusion score 
and the number of diseased vessels was 0.90.) Disease in the left main vessel was considered clinically 
important if > 50% stenosis was observed. 
 
Risk-factor information 
Medical records and questionnaires we used to obtain data concerning obesity, alcohol consumption, smoking, 
and histories of hypertension, myocardial infarction, diabetes mellitus, and medication use for 3 months prior to 
catheterization. Persons were excluded from the current analyses if they reported use of oral contraceptives, sex 
hormones, thyroid or cholesterol-lowering medication, or had hypo- or hyperthyroidism. These restrictions 
eliminated 1074 patients, with persons using cholesterol-lowering drugs representing the largest number (n = 
446) of exclusions. As compared with non-diabetics, a greater proportion of diabetics were eliminated by these 
exclusions. However, the difference was statistically significant only for hyperthyroidism: whereas 13% of the 
diabetics were hyperthyroid, the corresponding percentage among nondiabetics was 7% (p = 0.02). 
 
Height and weight were used to calculate Quetelet Index (kg/m
2
). Persons were considered to be hypertensive if 
they reported using antihypertensive medication. (Analyses performed using the patients' response to a question 
concerning past history of hypertension yielded similar results.) Usual alcohol intake, including beer, wine and 
mixed drinks, was converted to ounces of absolute alcohol per week. A 5-point smoking scale, reflecting both 
frequency and duration of smoking (1: never smoked, 5: smoked two or more packs daily for ≥20 years) was 
calculated as previously described [21]. (Even after controlling for both age and the number of daily cigarettes, 
smoking duration was related to CAD severity: partial correlations between duration (years) and occlusion score 
were 0.18 (males) and 0.23 (females) among current smokers, p < 0.01 for each association.) Smoking and 
alcohol data were available for 87% of the study population. 
 
Following an overnight fast, blood samples were collected before arteriography. Plasma levels of total 
cholesterol and triglycerides were measured using automated procedures [27-29] in a standardized laboratory 
that is monitored by the Centers for Disease Control. Beginning in 1977, levels of HDL cholesterol were meas-
ured using procedures employed by the Lipid Research Clinics [29]; these measurements were available for 
22% (n = 1230) of the patients in the current study. The ratio of total to HDL cholesterol was used as an 
estimate of the atherogenicity of each person's lipoprotein profile [30]. 
 
Definition of diabetes mellitus 
Diabetic status was determined by using responses to three items on a questionnaire administered before 
catheterization: 
 
1. Has your doctor ever said that you had diabetes? 
 
2. Are you now taking or have taken diabetes pills or insulin shots within the past 3 months? 
 
3. Have you been on a diet within the last year for diabetes? 
 
Patients who responded "no" to all three questions (n = 5154) were considered to be non-diabetic. Persons were 
classified as diabetic if they had been told by a physician that they were diabetic and were using either 
 
a. diet alone (n = 161), 
 
b. medication alone (n = 42), or 
 
c. both medication and diet (n = 234) 
 
for control. In addition, 29 patients who reported using antidiabetic medication, but responded "no" to question 
1 were also classified as diabetic. Unfortunately, fasting glucose levels were not available to confirm the 
identification of the diabetic patients. 
 
Overall, there were 466 diabetics in the current analyses. Information concerning (1) the medication (insulin vs 
oral hypoglycemics) used for control, and (2) the duration and severity of diabetes was not obtained. However, 
the proportion of diabetics taking medication who used  only oral hypoglycemics ranged from 70% [23] to 90% 
[24] in other arteriography studies. 
 
Statistical analyses 
The prevalence of diabetes was calculated for each sex according to 10-year age intervals, and levels of CAD 
and various risk factors were compared between diabetics and nondiabetics using 1-tests and chi-square tests. 
Analysis of covariance was also performed to control for small differences in age, yielding virtually identical 
results. 
 
The relation of various risk factors to coronary artery occlusion was examined in non-diabetics and diabetics 
using Spearman correlation coefficients. Regression analyses were performed to determine whether the relation 
of diabetes to CAD existed independently of other risk factors, and standardized regression coefficients, 
calculated as β(SDx/SDy), are used to compare the importance of each predictor variable. (Age and age
2
 were 
expressed as deviations from the mean age (55.5 years) to reduce multicollinearity [31].) Possible effect 
modifiers were examined in both stratified and regression [32] analyses. A backwards elimination procedure 
was used to delete nonsignificant (p > 0.05) diabetes x risk factor interaction terms while controlling for the 





As background material, Fig. 1 shows the sex- and age-specific prevalence of diabetes among patients 
undergoing coronary arteriography. Overall, 8% of both males (381/4585) and females (85/1035) were 
classified as diabetic. In addition, the prevalence of diabetes increased with age, reaching 10.4% among 60-69-
yearolds. Approximately three-fourths of the diabetics (n = 362) were between 50 and 69 years of age. 
 
Table 1 shows mean levels of selected characteristics according to diabetic status. Although the prevalence of 
chest pain was only slightly elevated among diabetics, larger differences were seen for both hypertension and 
previous myocardial infarction. As compared with non-diabetics, diabetics also had more extensive CAD and 
adverse levels of several risk factors, with most differences being proportionately larger among females. For 




Additional analyses (data not shown) indicated that diabetics had increased CAD irrespective of the presence or 
duration ( < 1, 1-2, or >2 years) of chest pain. Diabetes was not associated with increased levels of total 
cholesterol, but mean triglyceride levels were 24 and 48 mg/dl higher among male and female diabetics, 
respectively. Diabetics also showed decreased levels of HDL cholesterol ( -2 mg/dl in males, -8 mg/dl in 
females), along with corresponding increases in total/HDL cholesterol. Differences in Quetelet Index were also 
seen: diabetes was associated with an average increase in weight of 5.3 kg (females) and 0.6 kg (males). 
 
 
The increased severity of CAD among diabetics was most pronounced in patients who had not suffered a 
previous myocardial infarction (Table 2). Among these patients, the prevalence of 3-vessel disease was 
approximately doubled among diabetics, both in males (9 vs 19%) and females (4 vs 9%). A proportionately 
smaller increase in 3-vessel disease (18 to 26%) was seen in diabetic males who had experienced a myocardial 
infarction. However, diabetes was only weakly associated with increased CAD among males who reported a 
myocardial infarction p = 0.17). 
 
Regression analyses indicated that none of the risk factors showed a significantly stronger association with 
CAD among diabetics than among nondiabetics. Table 3 shows the relation of selected risk factors to coronary 
artery occlusion after stratifying by sex, previous myocardial infarction and diabetes. Among males, most 
associations were stronger in patients without a previous myocardial infarction, and among these patients, 
nondiabetics tended to show a stronger association between occlusion and levels of both total cholesterol and 
triglycerides than did diabetics. Among females, in contrast, associations between lipids and CAD tended to be 
stronger (but not significantly so) in diabetics than in nondiabetics, Using partial correlations to control for the 




Regression analyses, including a sex x diabetes interaction term, indicated that diabetes was associated (p = 
0.06) with a greater increase in occlusion among females than males. Analyses were then performed to assess 
whether the relation of diabetes to CAD was mediated through other risk factors, and Table 4 shows the results 
for each sex. Even after accounting  for the effects of covariates, diabetes remained associated with an increased 
occlusion score in both males (+28) and females (+41). (The association between diabetes and CAD was 
particularly evident among patients who had not experienced a myocardial infarction.) Overall, diabetes and 
other risk factors accounted for more of the variability in CAD among females than among males: R
2
 = 0.23 vs 
0.08. Although most risk factors were significantly related to CAD in both sexes, antihypertensive medication 
was associated with CAD only in females. 
 
 
Including HDL cholesterol as a covariate in these analyses reduced the sample size to 1118 persons, but 
diabetes remained related to increased occlusion (+29, p = 0.0002). A 1 mg/dl increase in HDL cholesterol was 
associated with a -1.8 decrease in the occlusion score. 
 
To examine whether other risk factors modified the relation of diabetes to CAD, stratified analyses were then 
performed. Within each risk-factor category, the mean occlusion score in nondiabetics, along with the increase 
among diabetics are shown in Table 5. For example, the 1083 male nondiabetics with cholesterol levels ≤200 
mg/dl had a mean occlusion score of 112, whereas male diabetics with comparable cholesterol levels had a 
mean score of 154, an increase of 42. 
 
The increased CAD among diabetics was similar across all age groups, and there was no evidence that the effect 
of diabetes in males was strongest at adverse levels of other risk factors. In contrast, at moderate to high levels 
of total cholesterol and triglycerides, female diabetics tended to show larger increases in CAD than did female 
diabetics with low levels of these lipids. In addition, whereas female diabetics who were using diet alone for 
control did not show increased coronary artery occlusion, those who used medication had a mean score of 133 
(Table 5, bottom right). Regression analysis (Table 6) indicated that even after covariate adjustment, use of anti-
diabetic medication in females remained associated with an increased (+66) occlusion score. (Similar increases 
in CAD were associated with medication irrespective of a previous myocardial infarction.) A comparable 
interaction between diabetes and antidiabetic medication was not observed among males. Although the sample 
size was greatly reduced if HDL cholesterol was included as a predictor variable, additional analyses indicated 
the relation of antidiabetic medication to CAD in females could not be attributed to levels of this lipoprotein 
cholesterol fraction. 
 
Table 6 also shows the multivariable relation of risk factors to CAD according to diabetic status and sex. 
Irrespective of diabetic status, CAD was more strongly related to levels of total cholesterol than to triglycerides, 
and anti-hypertensive medication was associated with increased CAD only in females. In addition, the effects of 









Results of this study indicate that among patients undergoing arteriography, diabetes is independently related to 
increased coronary atheroschlerosis, and that its impact is proportionately greater in females than in males. 
Although adverse levels of several risk factors were observed among diabetic patients, their increased CAD 
cannot be attributed to levels of plasma lipids, HDL cholesterol, obesity, hypertension, cigarette smoking, or 
alcohol intake. However, associations between lipids and coronary artery occlusion tended to be slightly 
stronger in diabetic (vs nondiabetic) females. In contrast, among males who had not suffered a myocardial 
infarction, the relation of triglyceride levels to CAD was weaker among diabetics. 
 
In agreement with current findings, several prospective studies [5-11] have shown that diabetics, especially 
female diabetics, are at increased risk for CHD even after adjustment for other risk factors. However, despite 
small numbers of CHD deaths among diabetics in many studies, it has been suggested that the risk of CHD may 
be particularly high among diabetics who smoke [16], are hypertensive [15], obese [17], hypertriglyceridemic 
[18], or who have low levels of HDL cholesterol [6]. In contrast, current results indicate that the effects of 
diabetes and other risk factors are mostly additive. The Whitehead [8] and Tecumseh [10] studies reported that 
CHD mortality among diabetics did not differ according to levels of total cholesterol, Quetelet Index, systolic 
blood pressure, or smoking status. 
 
Although arteriography allows for the assessment of coronary atherosclerosis, rather than its clinical 
manifestations, several limitations of this study design [33] should be considered Because of its cross-sectional 
nature, it is necessary to assume that risk factors measured at time of arteriography accurately reflect levels in 
the past. In addition, patients undergoing arteriography are highly selected, and are not representative of all 
persons with CAD: cases of sudden death and massive myocardial infarction would be missed. Furthermore, 
because of possible referral biases among diabetics, the current results may overestimate the prevalence (and 
severity) of CAD among diabetics. For example, although 31% of the diabetics identified in a community-based 
(Rochester, Minn.) study had macrovascular complications, the corresponding percentage among hospitalized 
diabetics was 47% [34, 35]. In addition, because of autonomic neuropathy resulting in the reduction of chest 
pain [36], it is possible that only those diabetics with severe CAD would have been referred for arteriography. 
Although the prevalence of diabetes in the current study etas similar to that reported in a representative sample 
of the U.S. population [37], because of possible biases associated with hospital-based studies of CAD and 
diabetes, the current results should be extrapolated with caution. 
 
In contrast, several other possible biases may have resulted in an underestimation of the association between 
diabetes and CAD. Obese female diabetics may suffer more lethal coronary events than do other diabetics [17], 
and if other risk factors also increase mortality among diabetics, associations may have been underestimated in 
the present study. Although controversial, diabetics may also have more diffuse CAD than do nondiabetics [19], 
and this could possibly reduce differences seen in arteriograms between a narrowed segment and a nearby 
"normal" arterial segment. In addition, the use of questionnaire data to assess diabetes likely resulted in false 
positives and false negatives. As suggested by Pearson [33], a diagnostic suspicion bias may have resulted in 
diabetics with less severe CAD symptoms undergoing arteriography. 
 
Nevertheless, similarities with findings population-based studies argue against the possibility of a marked bias 
in the current results. The independent relation of diabetes (and other risk factors) to CAD, as well as its 
differential impact between males and females are in agreement with results obtained in prospective studies. 
Differences in levels of risk factors between nondiabetic and diabetic persons in the current study also parallel 
population-based findings. Although diabetics do not necessarily have increased levels of total cholesterol [6. 
10, 11], diabetes (particularly in females) has been consistently related to obesity, elevated levels of blood 
pressure and plasma triglycerides [6, 7, 10, 11, 38], and to decreased levels of HDL cholesterol [38]. 
 
An unexpected finding was that the extent of coronary artery occlusion was particularly increased among 
females who were using anti-diabetic medications, even after adjustment for other risk factors. 
Hyperinsulinemia is often present in obese, type 2 diabetics or because of insulin therapy [39], and some 
evidence suggests that insulin may be causally related to atherosclerosis [40]. However, although diabetics who 
use oral hypoglycemics [3, 41, 42] or insulin [4, 43[ have been reported to be at increased risk for CHD, 
patients presenting with vascular disease have a high prevalence of carbohydrate abnormalities [44] and type 2 
diabetes [45]. Unfortunately, information concerning specific medication use (or duration of diabetes) was not 
collected in the current study, but other arteriography studies [19, 20, 23, 24] found that approximately three-
fourths of diabetics on medication were using oral hypoglycemics. Further studies are needed to determine 
whether antidiabetic medications are causally related to coronary atherosclerosis or reflect more severe diabetes 
of longer duration [18]. 
 
Results of this study indicate that diabetes is related to coronary atherosclerosis independently of other risk 
factors, and that its effect is relatively greater in females than in males. Although the independent contribution 
of diabetes atherosclerosis is not understood, abnormal protein composition, altered thrombogenic mechanisms 
or other genetic components [46] may be involved. However, the risk of clinical disease among diabetics, 
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